Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Immunotherapy-related adverse effects on 18F-FDG PET/CT imaging.

Gandy N, Arshad MA, Wallitt KL, Dubash S, Khan S, Barwick TD.

Br J Radiol. 2020 Feb 27:20190832. doi: 10.1259/bjr.20190832. [Epub ahead of print]

PMID:
32105505
2.

Interobserver agreement of the visual Herder scale for the assessment of solitary pulmonary nodules on 18F Fluorodeoxyglucose PET/computed tomography.

Ordidge KL, Gandy N, Arshad MA, Wallitt K, Soneji N, Khan S, Barwick TD.

Nucl Med Commun. 2020 Mar;41(3):235-240. doi: 10.1097/MNM.0000000000001146.

PMID:
31923048
3.

Imaging and Tissue Biomarkers of Choline Metabolism in Diffuse Adult Glioma: 18F-Fluoromethylcholine PET/CT, Magnetic Resonance Spectroscopy, and Choline Kinase α.

Grech-Sollars M, Ordidge KL, Vaqas B, Davies C, Vaja V, Honeyfield L, Camp S, Towey D, Mayers H, Peterson D, O'Neill K, Roncaroli F, Barwick TD, Waldman AD.

Cancers (Basel). 2019 Dec 7;11(12). pii: E1969. doi: 10.3390/cancers11121969.

4.

[18F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer.

Sharma R, Valls PO, Inglese M, Dubash S, Chen M, Gabra H, Montes A, Challapalli A, Arshad M, Tharakan G, Chambers E, Cole T, Lozano-Kuehne JP, Barwick TD, Aboagye EO.

Eur J Nucl Med Mol Imaging. 2019 Nov 21. doi: 10.1007/s00259-019-04532-z. [Epub ahead of print]

PMID:
31754793
5.

FDG-PET Imaging in Cervical Cancer.

Gandy N, Arshad MA, Park WE, Rockall AG, Barwick TD.

Semin Nucl Med. 2019 Nov;49(6):461-470. doi: 10.1053/j.semnuclmed.2019.06.007. Epub 2019 Jun 24. Review.

PMID:
31630730
6.

68Ga-DOTATATE PET/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumours.

Sharma R, Wang WM, Yusuf S, Evans J, Ramaswami R, Wernig F, Frilling A, Mauri F, Al-Nahhas A, Aboagye EO, Barwick TD.

Radiother Oncol. 2019 Dec;141:108-115. doi: 10.1016/j.radonc.2019.09.003. Epub 2019 Sep 18.

PMID:
31542317
7.

Reliability of dynamic contrast-enhanced magnetic resonance imaging data in primary brain tumours: a comparison of Tofts and shutter speed models.

Inglese M, Ordidge KL, Honeyfield L, Barwick TD, Aboagye EO, Waldman AD, Grech-Sollars M.

Neuroradiology. 2019 Dec;61(12):1375-1386. doi: 10.1007/s00234-019-02265-2. Epub 2019 Aug 7.

8.

Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements.

Eskian M, Alavi A, Khorasanizadeh M, Viglianti BL, Jacobsson H, Barwick TD, Meysamie A, Yi SK, Iwano S, Bybel B, Caobelli F, Lococo F, Gea J, Sancho-Muñoz A, Schildt J, Tatcı E, Lapa C, Keramida G, Peters M, Boktor RR, John J, Pitman AG, Mazurek T, Rezaei N.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):224-237. doi: 10.1007/s00259-018-4194-x. Epub 2018 Oct 22.

PMID:
30350009
9.

The utility of FDG-PET imaging in distinguishing PML-IRIS from PML in a patient treated with natalizumab.

Baheerathan A, McNamara C, Kalam S, Rane N, Barwick TD, Grote H, Nicholas R.

Neurology. 2018 Sep 18;91(12):572-573. doi: 10.1212/WNL.0000000000006213. No abstract available.

10.

Discovery of pre-therapy 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patients.

Arshad MA, Thornton A, Lu H, Tam H, Wallitt K, Rodgers N, Scarsbrook A, McDermott G, Cook GJ, Landau D, Chua S, O'Connor R, Dickson J, Power DA, Barwick TD, Rockall A, Aboagye EO.

Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):455-466. doi: 10.1007/s00259-018-4139-4. Epub 2018 Sep 1.

11.

PET/CT in Oncologic Imaging of Nodal Disease: Pearls and Pitfalls: RadioGraphics Fundamentals | Online Presentation.

Wallitt K, Yusuf S, Soneji N, Khan SR, Win Z, Barwick TD.

Radiographics. 2018 Mar-Apr;38(2):564-565. doi: 10.1148/rg.2018170143. Review. No abstract available.

PMID:
29528825
12.

Clinical PET Imaging in Prostate Cancer-Erratum.

Wallitt KL, Khan SR, Dubash S, Tam HH, Khan S, Barwick TD.

Radiographics. 2017 Nov-Dec;37(7):2208. doi: 10.1148/rg.2017174014. No abstract available.

PMID:
29131776
13.

What's New in Imaging for Gynecologic Cancer?

Khan SR, Arshad M, Wallitt K, Stewart V, Bharwani N, Barwick TD.

Curr Oncol Rep. 2017 Nov 6;19(12):85. doi: 10.1007/s11912-017-0640-3. Review.

PMID:
29105030
14.

Clinical utility of amyloid PET imaging with (18)F-florbetapir: a retrospective study of 100 patients.

Carswell CJ, Win Z, Muckle K, Kennedy A, Waldman A, Dawe G, Barwick TD, Khan S, Malhotra PA, Perry RJ.

J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):294-299. doi: 10.1136/jnnp-2017-316194. Epub 2017 Oct 10.

15.

Clinical PET Imaging in Prostate Cancer.

Wallitt KL, Khan SR, Dubash S, Tam HH, Khan S, Barwick TD.

Radiographics. 2017 Sep-Oct;37(5):1512-1536. doi: 10.1148/rg.2017170035. Epub 2017 Aug 11. Review.

PMID:
28800286
16.

FDG PET/CT Pitfalls in Gynecologic and Genitourinary Oncologic Imaging.

Lakhani A, Khan SR, Bharwani N, Stewart V, Rockall AG, Khan S, Barwick TD.

Radiographics. 2017 Mar-Apr;37(2):577-594. doi: 10.1148/rg.2017160059. Review.

PMID:
28287942
17.

FDG Uptake by Prosthetic Arterial Grafts in Large Vessel Vasculitis Is Not Specific for Active Disease.

Youngstein T, Tombetti E, Mukherjee J, Barwick TD, Al-Nahhas A, Humphreys E, Nash J, Andrews J, Incerti E, Tombolini E, Salerno A, Sartorelli S, Ramirez GA, Papa M, Sabbadini MG, Gianolli L, De Cobelli F, Fallanca F, Baldissera E, Manfredi AA, Picchio M, Mason JC.

JACC Cardiovasc Imaging. 2017 Sep;10(9):1042-1052. doi: 10.1016/j.jcmg.2016.09.027. Epub 2017 Jan 18.

18.

Cervical Cancer Staging: A Resident's Primer: Women's Imaging.

Raithatha A, Papadopoulou I, Stewart V, Barwick TD, Rockall AG, Bharwani N.

Radiographics. 2016 May-Jun;36(3):933-4. doi: 10.1148/rg.2016150173. Review. No abstract available.

PMID:
27163600
19.

Molecular imaging in cervical cancer.

Khan SR, Rockall AG, Barwick TD.

Q J Nucl Med Mol Imaging. 2016 Jun;60(2):77-92. Epub 2016 Feb 9. Review.

20.

Post-Radiation Therapy Imaging Appearances in Cervical Carcinoma.

Papadopoulou I, Stewart V, Barwick TD, Park WH, Soneji N, Rockall AG, Bharwani N.

Radiographics. 2016 Mar-Apr;36(2):538-53. doi: 10.1148/rg.2016150117. Epub 2016 Feb 5. Review.

PMID:
26849153

Supplemental Content

Loading ...
Support Center